Search Results for

Showing 1 - 10 of 413 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. ARVO Education

    ARVO Education Online Education Meet presentations Education Courses

  3. Contact Us

    Contact us ARVO Administrative Office ARVO 1801 Rockville Pike, Suite 400              Rockville, Md.  20852 USA Email:   Telephone: + Main Fax: + Journals Fax: +   Contact the ARVO team Membership and general inquiries     ARVO Foundation for Eye Research     Finance and accounting, including  accounts payable and receivable    

  4. Telling the story of OCT

    Telling the story of OCT Optical coherence tomography (OCT) is a technology invented by ARVO members that helps preserve patients' sight, saves taxpayers billions of dollars and enables further discoveries in science and medicine. See how ARVO has shared the impact of OCT with vision scientists, patients, and policymakers.  OCT projects

  5. Advocacy and Outreach

    Advocacy and Outreach Committee Advocacy and Outreach Committee Description Under the direction of the Board of Trustees, the Advocacy and Outreach Committee (AOC) develops and implements activities that influence research policy and funding decisions globally; increases members’ interest and ability to educate the public and policymakers about the importance of vision research; increases public awareness of ARVO and vision research; and establishes ARVO as a trusted source of information. I

  6. Annual Meeting Program Committee

    Annual Meeting Program Committee Annual Meeting Program Committee Description The Annual Meeting Program Committee (AMPC), under the direction of the Executive Vice President, is responsible for the content of the scientific portion of the ARVO Annual Meeting. Composition The members of each Scientific Section and Cross-sectional Group elect an AMPC member from the lists of current ARVO voting members (Regular, Sustaining, or Life members) each year. The Executive Vice President serves as